El-Lilly And Company: The Standard Gravurexa Case

Ely Lilly and Company
El- Lilly: A pharmaceutical company was founded by a 38 year-old pharmacist and El lilly in May 1876, it was founded in Indianapolis, USA. By opening the door to a small laboratory. Currently it has its headquarter in Indianapolis Indiana, USA, with 38,000 employees worldwide. El-lilly focuses on meeting some of the world’s most urgent medical needs, in the areas of oncology, cardiovascular disease, diabetes, critical care, neuroscience, men’s health and musculoskeletal. El-Lilly has competitive advantage indulging world class scientist in its research and development to produce highest quality of medicine that would solve the world medical need on the areas of it focuses. Profitability by net income is $(mill) 4,088.6
With this cooperation, they gain strong alliances with different companies. The two main ethical issues in the last years consist in two court cases: the first one is the Standard Gravure shooting and the second one is the Zyprexa case. The Standard Gravure shooting involved Joe Wesbecker, a pressman suffering of mental illness, who entered his former workplace and murdered 8 people, before killing himself. Since it was verified that the murder was under the effect of Prozac during the fact, the relatives of the victims sued Eli Lilly and Company. It was the first of 160 cases pending against Prozac, which represented almost one third of all Lilly’s sales. Lilly won the case but was accused by the judge to have agreed the development of the process with the lawyers from the other side. Surprisingly, Prozac’s sales and Lilly’s credibility were not seriously damaged by the incident. Lilly was also sued and pleaded guilty for hiding some collateral effects of the drug Zyprexa, which caused diabetes. The company was established to pay $ 1.42bilion. The only way to address these issues is to see if any future problems occur, and tackle them when they do. They should be penalized if some of the side effects are hidden or if something goes wrong, maybe due to high dosage or the wrong substance used. For now, it seems that Lilly is looking at things from a business perspective; it seems more profitable to be honest with each product developed and not to hide any side effects, because in the long-run it will be in their favor. Lilly is trying to build strong relationships with customers and intend to create trust from the government, stakeholders and from the population. If these negative occurrences happen frequently, there should be some sort of court ruling, maybe to put an end to testing and make the company limited to the sales of already-tested products. This way, the company could continue